JPRN-UMIN000048476
Recruiting
未知
ong-term follow up study after transplantation of human iPSC-derived dopaminergic progenitors in the treatment of Parkinson's Disease - Long-term follow up study after transplantation of human iPSC-derived dopaminergic progenitors in the treatment of Parkinson's Disease
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Kyoto University Hospital
- Enrollment
- 7
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Serious communication problems (to ensure safety during examinations). 2\. Bad general condition (such as abnormal vital signs). 3\. Serious infectious and other complications. 4\. Women who are pregnant or may be pregnant. Women who are breastfeeding. 5\. Participants who are judged to be inappropriate to be involved by the investigators.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Observational study one year after transplantation of iPS cell-derived neural precursor/stem cells for spinal cord injuryspinal cord injuryJPRN-UMIN000050104Keio University4
Completed
Not Applicable
ong term follow-up of perichondrial transplants for the repair of cartilage defects in the human knee by 7 tesla MRIcartilage defectosteochondral defect10043237NL-OMON45034Maastricht Universitair Medisch Centrum14
Active, not recruiting
Phase 1
A study to evaluate the long-term safety of patients with advanced lymphoid malignancies who have been previously administered with UCART19Advanced lymphoid malignanciesMedDRA version: 20.0Level: LLTClassification code 10060390Term: Leukaemia lymphoblastic acuteSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2016-000297-38-BEInstitut de Recherches Internationales Servier (I.R.I.S)200
Active, not recruiting
Phase 1
A study to evaluate the long-term safety of patients with advanced lymphoid malignancies who have been previously administered with UCART19Advanced lymphoid malignanciesMedDRA version: 20.0Level: LLTClassification code 10060390Term: Leukaemia lymphoblastic acuteSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2016-000297-38-FRInstitut de Recherches Internationales Servier (I.R.I.S)200
Active, not recruiting
Phase 1
A study to evaluate the long-term safety of patients with advanced lymphoid malignancies who have been previously administered with UCART19Advanced lymphoid malignanciesMedDRA version: 20.0 Level: LLT Classification code 10060390 Term: Leukaemia lymphoblastic acute System Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2016-000297-38-ESInstitut de Recherches Internationales Servier (I.R.I.S)200